new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Schering Corporation
Schering Corporation x26 Pharmacopeia Drug Discovery Inc
Schering Corporation Patent Department K 6 1 1990
Schering Corporation Canji Inc
Schering Corporation And Inserm
Schering Corporation A New Jersey Corporation
Schering Corporation And Albany Molecular Research Inc
Schering Corporation Sechering plough Corporation
Schering Corporation_20100128
Schering Corporation_20100121
Schering Corporation_20100107
Schering Corporation Schering Plough Corporation
  

Schering Corporation patents

Recent patent applications related to Schering Corporation. Schering Corporation is listed as an Agent/Assignee. Note: Schering Corporation may have other listings under different names/spellings. We're not affiliated with Schering Corporation, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Schering Corporation-related inventors




Date Schering Corporation patents (updated weekly) - BOOKMARK this page
05/22/14Engineered anti-tslp antibody
02/27/14Heterocyclic aspartyl protease inhibitors
02/13/14Aldosterone synthase inhibitors
10/24/13Biomarkers for psoriasis
06/20/13Factor ixa crystals, related complexes and methods
03/21/13Modulation of pilr to treat immune disorders
01/03/13Engineered anti-tslp antibody
01/03/13Engineered anti-tslp antibody
11/08/12Interleukin-10 antibodies
11/08/12Antibody purification
11/01/12Use of cytokine expression to predict skin inflammation; methods of treatment
11/01/12Heterocyclic aspartyl protease inhibitors
10/18/12Use of il-33 antagonists to treat fibrotic diseases
10/18/12Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
10/11/12Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis c
10/11/12Fdf03 antibodies and uses thereof
09/13/12Ox2 receptor homologs
09/13/12Heterocyclic aspartyl protease inhibitors
09/13/12Heterocyclic aspartyl protease inhibitors
09/13/12Aspartyl protease inhibitors
09/06/12Uses of mammalian cytokine; related reagents
09/06/12Mammalian cx3c chemokine antibodies
08/30/12Engineered anti-tslp antibody
08/30/12Process for preparing a 2-alkynyl substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine
08/16/12Methods for modulating il-33 activity
08/16/12Heterocyclic amide compounds as protein kinase inhibitors
08/09/12April antagonists and methods of use
08/02/12Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions and their use
07/26/12Anti-gitr antibodies
07/26/12Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
07/26/12Inhibitors of fatty acid binding protein (fabp)
07/19/12Mammalian cytokine; related reagents
07/12/12Mdl-1 uses
06/28/12Mammalian genes; related reagents and methods
06/21/12Pathogenic th17 cells; related reagents and methods
06/14/12Engineered anti-il-23r antibodies
06/14/12Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
06/07/12Uses of il-174 antagonists for inhibiting a th2 immune response
05/31/12Use of mometasone furoate for treating airway passage and lung disease
05/24/12Modulation of pilr receptors to treat microbial infections
05/17/12Modulation of pilr receptors to treat sepsis
05/17/12Mammalian receptor proteins; related reagents and methods
05/10/12Mammalian cytokines; related reagents
05/03/12Mammalian receptor proteins; related reagents and methods
05/03/12Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
04/26/12Agglomerate formulations including active pharmaceutical agents with targeted particle sizes
04/26/12Agglomerate formulations useful in dry powder inhalers
04/19/12Mammalian cell surface antigens; related reagents
04/05/12Npc1l1 orthologues
03/29/12Npc1l1 (npc3) and methods of use thereof
03/08/12Stable pharmaceutical drug products
03/01/12Uses of mammalian cytokine; related reagents
03/01/12Methods of alleviating or treating signs and/or symptoms associated with moderate to severe parkinson's disease
03/01/12Processes of making and using pharmaceutical formulations of antineoplastic agents
02/16/12Plasmid system for multigene expression
02/09/12Nasal spray device
02/09/12Light blocking container with viewing window for photosensitive compounds
02/09/12Uses of il-23 agonists and antagonists; related reagents
02/09/12Interferon-alfa sensitivity biomarkers
02/02/12Light blocking container with content viewing window and contrast background
02/02/12Synthesis of substituted-3-aminopyrazoles
01/26/12Elastomeric discharge member for nasal delivery device
01/26/12Isolated mammalian monocyte cell genes; related reagents
01/26/12Corticosteroid compositions and methods of treatments thereof
01/26/12Bicyclic compounds as inhibitors of diacyglycerol acyltransferase
Patent Packs
01/26/12Pharmaceutical formulations
01/12/12Monocyte-derived nucleic acids and related compositions and methods
01/05/12Phthalazine-containing antidiabetic compounds
12/29/11Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
12/22/11Bridged and fused antidiabetic compounds
12/22/11Bridged and fused heterocyclic antidiabetic compounds
12/22/11Pentafluorosulpholane-containing antidiabetic compounds
12/15/11Pegylated interleukin-10
11/24/11Deuterated compounds as hepatitis c virus (hcv) inhibitors
11/24/11Compounds for the treatment of inflammatory disorders
11/24/11Compounds for the treatment of inflammatory diseases
11/24/11Il-8 biomarker for monitoring cancer treatment
11/17/11Heterocyclic aspartyl protease inhibitors
11/17/11Mcp1-ig fusion variants
11/03/11Everninomicin biosynthetic genes
Patent Packs
10/27/11C21 thioethers as glucocorticoid receptor agonists
10/27/11Methods of treatment
10/27/11Pyrimidine derivatives as gpcr modulators for use in the treatment of obesity and diabetes
10/27/11Bicyclic heterocycle derivatives and methods of use thereof
10/20/11Fdf03 antibodies and uses thereof
10/20/11Gamma secretase modulators
10/20/11Purification of recombinantly produced interferon
10/13/11Mono- and di-peg il-10 production; and uses
10/13/11Feed supplement for mammalian cell culture and methods of use
10/06/11Mammalian receptor proteins; related reagents and methods
10/06/11Bicyclic pyranone derivatives and methods of use thereof
10/06/11Pyridopyrimidine derivatives and methods of use thereof
09/29/11Tetrahydropyranochromene gamma secretase inhibitors
09/29/116-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
09/22/11Lyophilized formulations of engineered anti-il-23p19 antibodies
09/15/11Uses of il-174 antagonists for inhibiting a th2 immune response
09/08/11Betag1-igg intron for enhanced anti-igf1r expresson
09/01/11Inflammatory bowel disease biomarkers and related methods of treatment
09/01/11Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
08/25/11Mcp1 fusions
08/25/11Pharmaceutical formulations of an hcv protease inhibitor in a solid molecular dispersion
08/18/11Pulmonary disease treatment
08/11/11Mammalian cytokines; related reagents and methods
08/04/11Intranasal compositions, dosage forms and methods of treatment
08/04/11Mammalian cx3c chemokine antibodies
08/04/11Cyclopropylchromene derivatives as modulators of the alpha-2c receptor
07/28/11C20-c21 substituted glucocorticoid receptor agonists
07/28/11Inhalation drug products, systems and uses
07/21/11Mammalian cytokines; related reagents and methods
07/21/11Spiro-imidazolone derivatives as glucagon receptor antagonists
Social Network Patent Pack
07/07/113-heterocyclic substituted indole derivatives and methods of use thereof
07/07/11Mammalian genes; related reagents and methods
07/07/11Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
07/07/11Bicyclic heterocycle derivatives and methods of use thereof
06/30/11Packages and inserts thereof with guide wall for dispensing medicinal units
06/30/11Engineered anti-il-23r antibodies
06/23/11Packages and inserts useful for dispensing medicines
06/23/11Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
06/16/11Engineered anti-il-23p19 antibodies
06/16/11Process for the synthesis of azetidinones
Patent Packs
06/09/11Uses of mammalian cytokine; related reagents
06/09/11Mammalian cytokines; related reagents
06/02/11Heterocyclic urea and thiourea derivatives and methods of use thereof
06/02/11Mammalian receptor proteins; related reagents and methods
06/02/11Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
05/26/11Process and intermediates for the synthesis of heterocyclic substituted piperazines with cxcr3 antagonist activity
05/19/11Anti-reg4 antibodies
05/12/11Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
04/21/11Use of pegylated il-10 to treat cancer
04/07/11Gamma secretase modulators
03/17/11Pegylated interleukin-10
03/17/11Combination therapies comprising par1 antagonists with nar agonists
03/17/11Polycyclic guanine derivatives and use thereof
03/10/11Substituted bicyclic piperidinyl-and piperazinyl- sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
03/03/11Antibodies to il-17a
02/24/11Thiazole carboxamide derivatives and their use to treat cancer
02/17/11Antibodies to il-17a
02/10/11Treatments for flaviviridae virus infection
02/10/11Anti-pcsk9 and methods for treating lipid and cholesterol disorders
02/03/11Everninomicin biosynthetic genes
01/27/11Engineered anti-tslpr antibodies
01/27/11Human receptor proteins; related reagents and methods
01/20/11Anti-igf1r
01/13/11Gamma secretase modulators
01/13/11Methods of treating copd
01/06/11Uses of mammalian cytokine; related reagents
01/06/11Engineered anti-il-23 antibodies
01/06/11Hydrogen chloride salt of a substituted 5-oxazol-2-yl-quinoline compound and a process for the production thereof
01/06/11Substituted amide beta secretase inhibitors
12/30/10Use of bispecific antibodies to regulate immune responses
Patent Packs
12/30/10Thiazole derivatives as protein kinase inhibitors
12/30/10Processes of making and using pharmaceutical formulations of antineoplastic agents
12/23/105, 6-ring annulated indole derivatives and use thereof
12/23/10Syn3 compositions and methods
12/23/10Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof
11/25/10Pegylated interleukin-10
11/25/10Novel jnk inhibitors
11/25/10Gamma secretase modulators
11/25/10Gamma secretase modulators
11/18/10Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto
11/18/10Use of il-23 antagonists for treatment of infection
11/18/10Heterocyclic aspartyl protease inhibitors
11/11/10Pregnane x receptor compositions, crystals and uses thereof
11/04/10Mammalian receptor proteins; related reagents and methods
10/28/10Engineered anti-il-23p19 antibodies
10/21/10Human receptor proteins; related reagents and methods
10/21/10Akt3 polypeptides
10/21/10Hdm2 polypeptides
10/21/10Exo-selective synthesis of himbacine analogs
10/14/103-aminosulfonyl substituted indole derivatives and methods of use thereof
Social Network Patent Pack
10/14/10Mammalian genes; related reagents and methods
10/14/10Mammalian receptor proteins; related reagents and methods
10/07/10Use of cytokine expression to predict skin inflammation; methods of treatment
10/07/10Gamma secretase modulators
10/07/10Gamma secretase modulators
10/07/10Process for the preparation of 6,6- dimethyl-3-azabicyclo-[3.1.0]-hexane compounds and enantiomeric salts thereof
09/30/10Gamma secretase modulators
09/30/10Heterocyclic aspartyl protease inhibitors
09/30/10Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment
09/30/10Oxypiperidine derivatives and methods of use thereof
09/23/102,3-substituted azaindole derivatives for treating viral infections
09/23/10Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease
09/23/10Methods of treating cell proliferative disorders using a compressed temozolomide dosing schedule
09/09/10Methods to treat and/or prevent mucositis
09/09/10Nitrogen-containing heterocyclic compounds and methods of use thereof
09/02/10Mdl-1 uses
08/19/10Purified mammalian cytokines; related reagents and methods
08/19/10Methods of treatment using intravenous formulations comprising temozolomide
08/12/10Mammalian cytokines; related reagents and methods
08/12/10Interleukin-10 antibodies
Social Network Patent Pack
08/05/104, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
08/05/10Diaryl morpholines as cb1 modulators
07/29/10Methods for crystallizing erk2 polypeptides
07/22/10Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof
07/15/10Macrocyclic beta-secretase inhibitors
07/15/10Antibodies to cd200r
07/15/10Novel jnk inhibitors
07/08/10Mcp1 fusions
07/01/10Engineered anti-tslp antibody
07/01/10Engineered anti-il-23r antibodies
06/24/10Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors
06/24/10Treatment method
06/17/10Methods of modulating maternal-fetal tolerance
06/10/10Pharmaceutical compositions for the treatment of asthma
06/10/10Combination therapy for proliferative disorders
06/10/10Methods and compositions for treating cancer
06/10/10Uses of mammalian cytokine; related reagents
06/10/10Benzimidazole derivatives and methods of use thereof
06/10/10Pharmaceutical formulations
06/10/10Pyrimidinedione derivatives and methods of use thereof
06/10/10Functionally selective alpha2c adrenoreceptor agonists
06/10/10Process for preparing (1r,2s,5s)-n-[(1s)-3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2s)-2-[[[(1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
06/10/10Compounds for the treatment of inflammatory disorders
06/10/10Process for the preparation of 6,6-dimethyl-3-azabicyclo-[3.1.0]- hexane compounds utilizing bisulfite intermediate
06/03/10Combination therapy for treatment of immune disorders
06/03/10Uses of mammalian cytokine; related reagents
06/03/10Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/10Gamma secretase modulators
06/03/10Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2h-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors
06/03/10Synthesis of diethylphosphonate
Social Network Patent Pack
05/27/10Mammalian cell membrane proteins; related reagents
05/27/10Mammalian cytokines; related reagents and methods
05/27/10Mammalian cytokines; related reagents and methods
05/20/10Methods for inhibiting protein kinases
05/13/10Peptide viral entry inhibitors
05/13/10Mammalian expression vector puhab
05/13/10Compounds for the treatment of inflammatory disorders
05/06/10Engineered anti-il-23p19 antibodies
05/06/10Methods of treating ovarian cancer
05/06/10Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereof
04/29/10Mammalian genes; related reagents and methods
04/29/10Tablet formulations containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom
04/22/10Pharmaceutical compositions
04/22/104,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
04/15/10Mammalian chemokines; related reagents
04/08/10Dispenser dose counter mechanism
04/08/10Chemokines as adjuvants of immune response
04/08/10Process and intermediates for the synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
04/08/10Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors
04/01/10Ph sensitive matrix formulation
03/25/10Method for reducing protease activity in plant hydrolysate
03/18/10Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
03/18/10Aspartyl protease inhibitors
03/11/10Macrocyclic heterocyclic aspartyl protease inhibitors
03/11/10Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds
02/25/10Hydrochloride salts of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
02/18/10Mammalian cytokine; related reagents
02/11/10Synthesis of ccr5 receptor antagonists
02/04/10Substituted piperazines as cb1 antagonists







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Schering Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Schering Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';